Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease

Overview of attention for article published in Frontiers in Chemistry, May 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 40 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 38,614 followers.

RT @agingdoc1: Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease…

18 Oct 2022

Reply Repost Favourite

Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease https://t.co/maR0sdUUJi

16 Oct 2022

Reply Repost Favourite

New Research: Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease: Non-alcoholic fatty liver disease (NAFLD) is characterized by excessive lipid accumulation and liver… https://t.co/jT

28 May 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.